Skip to main content
Caplight Logo









Sorriso Pharmaceuticals

Sorriso Pharmaceuticals

Private
Sandy, UtahHealthcare & Life Scienceshttps://sorrisopharma.com/

Last Round

Series A

Dec 22, 2021

Est. Valuation

$50M

Total Funding Raised

$31M

Company Overview

Sorriso Pharmaceuticals is a biopharmaceutical company developing oral disease-modifying antibodies for the treatment of inflammatory diseases such as Crohn's disease and ulcerative colitis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysingle-domain antibodyoral biologicsinflammatory bowel diseaseIBDnanobodydrug discoverygut-restricted therapyCrohn's diseaseulcerative colitisbiopharmaclinical-stage biotechbispecific antibodyanti-TNFdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sorriso Pharmaceuticals Comparables

Compare Sorriso Pharmaceuticals with similar companies based on industry and business-model similarity.

Sorriso Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Caldera Therapeutics
88%
GAT Biosciences S.L.
86%
Mage Biologics Inc.
84%

Sorriso Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 22, 2021

Sorriso Pharmaceuticals Investors

Notable investors and investment history

Sorriso Pharmaceuticals investors
InvestorRounds
A. M. Pappas & AssociatesSeries A
New Enterprise Associates (NEA)Series A
Lundbeckfonden BioCapitalSeries A
Arix BioscienceSeries A
Biovision VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 42% MoM.

Sorriso Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sorriso Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sorriso Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersSandy, Utah
Employee Range14
Year Founded2020
Last FundingDec 22, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?